Clinical trial
A Prospective PMCF Study of Paclitaxel Drug-coated Balloon Angioplasty for the Treatment of Symptomatic Peripheral Arterial Disease
NCT06832631 is registered in ClinicalTrials.gov with OrbusNeich as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective PMCF Study of Paclitaxel Drug-coated Balloon Angioplasty for the Treatment of Symptomatic Peripheral Arterial Disease
- Lead sponsor
- OrbusNeich
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- May 22, 2025
- Completion date
- June 30, 2029
- Enrollment
- 283 (actual)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.
peripheral arterial disease, peripheral arterial occlusive disease